Why is Zim Laboratories falling/rising?

As of 02-Jul, Zim Laboratories Ltd is currently priced at 110.70, reflecting a slight increase of 0.15 (0.14%). The stock's performance today is in line with its sector, although it has shown a decline of 1.16% over the past week, while achieving a notable increase of 25.80% over the past month. Despite being higher than the 20-day, 50-day, 100-day, and 200-day moving averages, it is lower than the 5-day moving average. The stock has experienced a decrease in investor participation, with delivery volume falling by 2.66% against the 5-day average. While the stock is trading at a discount compared to its peers and has an attractive valuation, it has also faced challenges, including a significant drop in profits by 29.5% over the past year and negative results for the last four consecutive quarters.
In the broader market context, the Sensex has increased by 0.79% over the past week, contrasting with Zim Laboratories' decline. The stock's year-to-date return of 3.46% is notably lower than the Sensex's 6.75% gain. The company's long-term growth prospects appear poor, with net sales growing at an annual rate of only 6.41% over the last five years, which may contribute to the lack of confidence from domestic mutual funds, who hold no stake in the company. This combination of factors suggests that while the stock has seen some short-term gains, the overall sentiment remains cautious due to its declining profitability and lack of institutional support.